We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetic Test Indicates a Young Man's Chances of Becoming Bald

By Labmedica staff writers
Posted on 24 Jan 2008
Print article
A simple consumer-friendly test has been developed that provides an accurate and understandable genetic analysis of a man's likelihood of developing male pattern baldness (androgenetic alopecia).

A man can learn about his genetic predisposition to balding before he reaches the age of 40. People who have certain variations in their X-chromosome are likely (95.1-98.1%) to develop pattern baldness before age 40. The test is simple--the man swabs his mouth (inside cheek) for several seconds and returns the swab to lab. The test is performed anonymously and the results delivered via a secure and private Web site.

The information provided by the test, which has been named HairDX, enables the consumer to make informed decisions about what approach, if any, he should take, including discussing hair loss with a qualified physician. HairDX.com also provides a support center with access to a registered nurse.

HairDX (Irvine, CA, USA) developed the genetic baldness test and has announced its commercial release. The company was founded by scientists and specialists in genetic analysis and hair therapies. It is created to help people make the right decisions about hair care, treatment, and restoration by providing accurate and accessible personalized scientific information.

The genetic analysis is performed by BioServe (Beltsville, MD, USA), a laboratory specializing in the processing, development, and validation of diagnostic tests for the practice of personalized, predictive, and preventive medicine. BioServe is a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory.

"The most common form of hair loss, androgenetic alopecia, is hereditary. Looking at your father's or grandfather's head has been an inaccurate, nonscientific barometer. The genetic revolution will enable patients and physicians to gain deeper understanding of hair loss,” said Peter Novak, M.D., Ph.D., a scientist at the University of Massachusetts Medical Center (Worcester, MA, USA). Dr Novak is an innovator in the field of stem cell therapies for treatment of hair loss.

"Each year, men in their 20s and 30s spend millions of dollars on pharmaceuticals, topical products, and other costly treatments trying to prevent baldness. Some of this is done by males who may not go bald in the first place,” said HairDX CEO Andy Goren.


Related Links:
HairDX
BioServe
University of Massachusetts Medical Center
New
Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Automated Nucleic Acid Extraction Instrument
EX9600
New
Bordetella Pertussis ELISA
NovaLisa Bordetella Pertussis IgA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.